FDA Inspection 1149825 — Julian D. Gillmore, M.D.
The FDA completed an inspection of Julian D. Gillmore, M.D. on July 30, 2021 in London. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 30, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- London (United Kingdom)
Additional Details
Clinical Investigator (CI)